Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS - No Study Results Posted

Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS (STAR)

This study has been completed.

Study NCT00573443 Information provided by Avanir Pharmaceuticals

First Received: December 13, 2007 Last Updated: June 24, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2009
Primary Completion Date:	June 2009 (Final data collection date for primary outcome measure)